Cancer, one of the most dangerous diseases with a high mortality rate, has attracted much
attention and interest. Advances in tissue engineering and microfluidics have led to the …

Cancer immunotherapy is the great breakthrough in cancer treatment as it displayed
prolonged progression-free survival over conventional therapies, yet, to date, in only a …

The interactions among tumour cells, the tumour microenvironment (TME) and non-tumour
tissues are of interest to many cancer researchers. Micro-engineering approaches and …

Despite significant achievements in the understanding and treatment of cancer, it remains a
major burden. Traditional therapeutic approaches based on the 'one-size-fits-all'paradigm …

The advances in cancer immunotherapy come with several obstacles, limiting its
widespread use and benefits so far only to a small subset of patients. One of the underlying …

Current biomedical models fail to replicate the complexity of human biology. Consequently,
almost 90% of drug candidates fail during clinical trials after decades of research and …

Interest in recapitulating in vivo phenomena in vitro using organ-on-a-chip technology has
grown rapidly and with it, attention to the types of fluid flow experienced in the body has …

Organ-on-a-chip devices have become a viable option for investigating critical physiological
events and responses; this technology has matured substantially, and many systems have …

Biomicrofluidics, a subdomain of microfluidics, has been inspired by several ideas from
nature. However, while the basic inspiration for the same may be drawn from the living …

The lymphatic vessel (LV) plays an important role in cancer biology as a major route for
tumor metastasis. Whereas, recent oncoimmunological approaches have focused its role in …